Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.30
Delayed Data
As of Dec 02
 +0.08 / +1.29%
Today’s Change
4.76
Today|||52-Week Range
8.29
-16.45%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.22
Today’s open6.06
Day’s range5.75 - 6.49
Volume20,211
Average volume (3 months)13,535
Market cap$30.5M
Dividend yield--
Data as of 12/02/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio31.5
Price/Sales2.32
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
HSGXHistogenics Corp-0.07-3.50%
CURNeuralstem Inc-0.00-0.78%
PLXProtalix Biotherapeu...-0.25-44.59%
CANFCan Fite Biopharma L...+0.05+2.33%
Data as of 12/02/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts


Search for Jobs